Karen L Tubridy - Net Worth and Insider Trading
Karen L Tubridy Net Worth
The estimated net worth of Karen L Tubridy is at least $164,277 dollars as of 2024-11-13. Karen L Tubridy is the SVP, Chief Development Officer of Akebia Therapeutics Inc and owns about 84,679 shares of Akebia Therapeutics Inc (AKBA) stock worth over $164,277. Details can be seen in Karen L Tubridy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen L Tubridy has not made any transactions after 2020-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen L Tubridy
Karen L Tubridy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen L Tubridy owns 3 companies in total, including Akebia Therapeutics Inc (AKBA) , Sesen Bio Inc (SESN) , and CARISMA Therapeutics Inc (CARM) .
Click here to see the complete history of Karen L Tubridy’s form 4 insider trades.
Insider Ownership Summary of Karen L Tubridy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | SVP & Chief Development Officer |
| SESN | Sesen Bio Inc | 2014-02-05 | Chief Development Officer |
| CARM | CARISMA Therapeutics Inc | 2014-02-05 | Chief Development Officer |
Karen L Tubridy Latest Holdings Summary
Karen L Tubridy currently owns a total of 1 stock. Karen L Tubridy owns 84,679 shares of Akebia Therapeutics Inc (AKBA) as of February 28, 2020, with a value of $164,277.
Latest Holdings of Karen L Tubridy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | 84,679 | 1.94 | 164,277 |
Holding Weightings of Karen L Tubridy
Karen L Tubridy Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen L Tubridy has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 3,454 shares on February 28, 2020, which brought Karen L Tubridy around $30,050.
Insider Trading History of Karen L Tubridy
- 1
Karen L Tubridy Trading Performance
Karen L Tubridy Ownership Network
Ownership Network List of Karen L Tubridy
Ownership Network Relation of Karen L Tubridy
Karen L Tubridy Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Karen L Tubridy is the SVP & Chief Development Officer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & General Counsel & Sec. Nicole R. Hadas , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Karen L Tubridy made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 149,723 shares made by Michel Dahan , a net sale of 106,103 shares made by Steven Keith Burke , and a net sale of 88,587 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 0 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 492,283 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,283 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Karen L Tubridy Mailing Address
Above is the net worth, insider trading, and ownership report for Karen L Tubridy. You might contact Karen L Tubridy via mailing address: Eleven Biotherapeutics, Inc., 215 First Street, Suite 400, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
